Guaifenesin Tablet, Extended Release
Product Images NDC 68001-561

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 68001-561). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Guaifenesin Extended Release Tablets 600 mg Blister Carton 80 Extended Release Tablets)

Packaging label for Guaifenesin extended-release tablets, 600 mg, oral dosage form, by BluePoint Laboratories. The label highlights 80 tablets per package, intended as an expectorant. The label includes directions, active ingredient details, drug facts, a barcode, and notes a 12-hour duration of action. Tablet images and various barcode and regulatory information are shown.*

FDA Label Image

Blister Pack (Guaifenesin Extended Release Tablets 600 mg Blister Foil.)

Label sheet for Guaifenesin 600 mg extended-release tablets, oral dosage form, by BluePoint Laboratories. The labels include the product name, strength, dosage form, barcodes, and manufacturing info, repeated multiple times with perforations for individual tablet push-through foil packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.